Positron Emission Tomography in Determining Stage of Esophageal Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to
determine the stage of esophageal cancer.
PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission
tomography determines tumor stage in patients with esophageal cancer.